Edwin P. Hui

14.7k total citations · 4 hit papers
170 papers, 8.9k citations indexed

About

Edwin P. Hui is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Edwin P. Hui has authored 170 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 63 papers in Otorhinolaryngology and 45 papers in Surgery. Recurrent topics in Edwin P. Hui's work include Head and Neck Cancer Studies (63 papers), Viral-associated cancers and disorders (45 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers). Edwin P. Hui is often cited by papers focused on Head and Neck Cancer Studies (63 papers), Viral-associated cancers and disorders (45 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers). Edwin P. Hui collaborates with scholars based in Hong Kong, China and United States. Edwin P. Hui's co-authors include Anthony T.�C. Chan, Brigette Ma, Frankie Mo, Melvin L.K. Chua, Joseph Wee, Benny Zee, Ann D. King, Stephen L. Chan, Tony Mok and K.C. Allen Chan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Edwin P. Hui

168 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nasopharyngeal carcinoma

2015 955 citations Edwin P. Hui, Anthony T.�C. Chan et al. profile →
Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

2017 501 citations K.C. Allen Chan, John K. S. Woo et al. profile →
Nasopharyngeal carcinoma: an evolving paradigm

2021 315 citations Kenneth C.W. Wong, Edwin P. Hui et al. profile →
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

2020 240 citations Anthony T.�C. Chan, Edwin P. Hui et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edwin P. Hui Hong Kong	47	4.0k	3.2k	2.2k	2.2k	2.1k	170	8.9k
George Fountzilas Greece	54	7.7k 1.9×	1.3k 0.4×	2.1k 1.0×	3.1k 1.4×	2.3k 1.1×	576	12.8k
Makoto Tahara Japan	43	4.1k 1.0×	2.1k 0.6×	653 0.3×	1.5k 0.7×	2.2k 1.1×	379	9.0k
K.C. Allen Chan Hong Kong	56	2.7k 0.7×	1.2k 0.4×	4.7k 2.1×	4.1k 1.9×	1.3k 0.6×	155	11.3k
Athanassios Argiris United States	47	4.2k 1.1×	3.5k 1.1×	923 0.4×	2.7k 1.3×	2.2k 1.0×	243	8.9k
Wilfried Budach Germany	51	2.7k 0.7×	1.8k 0.6×	1.8k 0.8×	1.8k 0.8×	3.6k 1.7×	334	10.4k
Nabil F. Saba United States	46	4.1k 1.0×	3.1k 1.0×	1.2k 0.6×	2.5k 1.1×	2.6k 1.2×	406	9.2k
Wael Sakr United States	56	3.0k 0.8×	1.7k 0.5×	2.2k 1.0×	3.1k 1.4×	2.9k 1.4×	214	11.4k
Kate Newbold United Kingdom	40	2.2k 0.6×	1.9k 0.6×	543 0.2×	1.2k 0.6×	2.4k 1.1×	143	9.3k
Bhumsuk Keam South Korea	50	6.1k 1.5×	573 0.2×	1.6k 0.7×	2.1k 1.0×	1.4k 0.7×	373	9.9k
Sylvie Rottey Belgium	39	4.1k 1.0×	2.2k 0.7×	949 0.4×	2.2k 1.0×	1.6k 0.8×	236	7.9k

Countries citing papers authored by Edwin P. Hui

Since Specialization

Citations

This map shows the geographic impact of Edwin P. Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin P. Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin P. Hui more than expected).

Fields of papers citing papers by Edwin P. Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin P. Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin P. Hui. The network helps show where Edwin P. Hui may publish in the future.

Co-authorship network of co-authors of Edwin P. Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin P. Hui. A scholar is included among the top collaborators of Edwin P. Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin P. Hui. Edwin P. Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

King, Ann D., Qi Yong H. Ai, W.K. Lam, et al.. (2024). Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging. JNCI Journal of the National Cancer Institute. 116(5). 665–672. 6 indexed citations

Hui, Connie W. C., Chi Hang Wong, Kwok Wai Lo, et al.. (2023). Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models. Investigational New Drugs. 41(5). 699–709. 2 indexed citations

Ai, Qi Yong H., Weitian Chen, Tiffany Y. So, et al.. (2020). Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx. American Journal of Neuroradiology. 41(12). 2339–2344. 9 indexed citations

Hui, Edwin P., Brigette Ma, W.K. Lam, et al.. (2020). Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy. Annals of Oncology. 31(6). 769–779. 72 indexed citations

Hui, Edwin P., Brigette Ma, Herbert H. Loong, et al.. (2018). Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study. Clinical Cancer Research. 24(5). 1030–1037. 41 indexed citations

Ai, Qi Yong H., Ann D. King, Darren M.C. Poon, et al.. (2018). Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx. Oral Oncology. 88. 124–130. 54 indexed citations

Chan, Stephen L., Winnie Yeo, Frankie Mo, et al.. (2017). A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma. Cancer. 123(20). 3977–3985. 24 indexed citations

Wu, Xinyin, Vincent CH Chung, Xin Liu, et al.. (2016). Acupuncture and Related Therapies for Symptom Management in Palliative Cancer Care. Medicine. 95(9). e2901–e2901. 102 indexed citations

Chung, Vincent CH, Xinyin Wu, Ping Lu, et al.. (2016). Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care. Medicine. 95(7). e2793–e2793. 54 indexed citations

10.

Zheng, Yong, Greg Parsonage, Xiaodong Zhuang, et al.. (2015). Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma. Cancer Immunology Research. 3(10). 1138–1147. 28 indexed citations

11.

Taylor, Graham S., Hui Jia, Kevin J. Harrington, et al.. (2014). A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer. Clinical Cancer Research. 20(19). 5009–5022. 138 indexed citations

12.

Hui, Edwin P.. (2013). Optimising systemic therapy in metastatic colorectal cancer. Hong Kong Journal of Radiology. 16. 1 indexed citations

13.

Hui, Edwin P., Graham S. Taylor, Hui Jia, et al.. (2013). Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients. Cancer Research. 73(6). 1676–1688. 146 indexed citations

14.

Wong, Chi Hang, Herbert H. Loong, Connie W. C. Hui, et al.. (2013). Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma. Investigational New Drugs. 31(6). 1399–1408. 27 indexed citations

15.

Hui, Edwin P., Brigette Ma, Ann D. King, et al.. (2011). Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation. Annals of Oncology. 22(6). 1280–1287. 81 indexed citations

16.

Lui, Vivian Wai Yan, Elaine Yue Ling Wong, Yeung Ho, et al.. (2009). STAT3 activation contributes directly to Epstein‐Barr virus–mediated invasiveness of nasopharyngeal cancer cells in vitro. International Journal of Cancer. 125(8). 1884–1893. 61 indexed citations

17.

Wong, Sze Chuen Cesar, Charles Ming Lok Chan, Brigette Ma, et al.. (2009). Clinical Significance of Cytokeratin 20-Positive Circulating Tumor Cells Detected by a Refined Immunomagnetic Enrichment Assay in Colorectal Cancer Patients. Clinical Cancer Research. 15(3). 1005–1012. 64 indexed citations

18.

Hui, Edwin P., Brigette Ma, Sing Fai Leung, et al.. (2008). Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 27(2). 242–249. 406 indexed citations

19.

Hui, Edwin P., Anthony T.�C. Chan, Francesco Pezzella, et al.. (2002). Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.. PubMed. 8(8). 2595–604. 263 indexed citations

20.

Rodrigo, M. R. C., Ling Ling Chan, & Edwin P. Hui. (1992). Flumazenil Reversal of Conscious Sedation for Minor Oral Surgery. Anaesthesia and Intensive Care. 20(2). 174–176. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact